Cargando…

Using Photovoice to explore patients' experiences with mental health medication: A pilot study

INTRODUCTION: The objective of this research is to explore and share the medication experience of those with a mental illness in order to gain understanding of the patient's medication perceptions as well as the impact of medication upon patients' lives. METHODS: Patients with a mental dis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Werremeyer, Amy B., Aalgaard-Kelly, Gina, Skoy, Elizabeth
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	College of Psychiatric & Neurologic Pharmacists 2016
Materias:	Open Submissions
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6007651/ https://www.ncbi.nlm.nih.gov/pubmed/29955462 http://dx.doi.org/10.9740/mhc.2016.05.142

Ejemplares similares

Exploration of Learning during an International Health Elective Using Photovoice Methodology
por: Werremeyer, Amy, et al.
Publicado: (2016)

Self-stigma of antidepressant users through secondary analysis of PhotoVoice data
por: Nelson, Erik, et al.
Publicado: (2018)

Photovoice as an intervention for college students living with mental illness: A pilot study
por: Werremeyer, Amy, et al.
Publicado: (2020)

A pilot study evaluating the effectiveness of a medicines education group in a mental health inpatient setting: A UK perspective
por: White, Daniel, et al.
Publicado: (2018)

Evaluation of clinical pharmacy services within the primary care–mental health integration model at the Tuscaloosa Veterans Affairs Medical Center
por: Parikh, Mamta, et al.
Publicado: (2016)

Implementation and evaluation of a pharmacist-run mental health treatment clinic via clinical video telehealth
por: Leach, Molly, et al.
Publicado: (2016)

A consumer-led intervention to improve pharmacists' attitudes toward mental illness
por: Rickles, Nathaniel M., et al.
Publicado: (2016)

Diuretics: A possible keystone in upholding cognitive health
por: DeLoach, Tyler, et al.
Publicado: (2018)

Hospitalizations and emergency room visits after initiation of long-acting injectable antipsychotics
por: Heesch, Chelsie B., et al.
Publicado: (2016)

A design and focus group evaluation of dietary choices tools for an underserved population
por: McMorris, Tressa, et al.
Publicado: (2016)

Mania possibly linked with bupropion for smoking cessation: A case report
por: Dwyer, Stephanie, et al.
Publicado: (2016)

Evaluation of the use of low-dose quetiapine and the risk of metabolic consequences: A retrospective review
por: Carr, Chelsea N., et al.
Publicado: (2016)

Identification, assessment, and management of pain in patients with advanced dementia
por: Malotte, Kasey L., et al.
Publicado: (2016)

Suicide prevention in pharmaceutical education: Raising awareness with inspiring stories
por: Vincent, Philippe D., et al.
Publicado: (2016)

Evaluation of adherence in patients prescribed long-acting injectable antipsychotics: A comparison of biweekly versus monthly administered neuroleptics
por: Carr, Chelsea N., et al.
Publicado: (2016)

Impact on length of stay and readmission rates when converting oral to long-acting injectable antipsychotics in schizophrenia or schizoaffective disorder
por: Chou, Fabienne, et al.
Publicado: (2016)

Quantitative and economic analysis of clinical pharmacist interventions during rounds in an acute care psychiatric hospital
por: Gunterus, Alicia, et al.
Publicado: (2016)

Management of migraine headaches in a chronic pain patient: A case report
por: Bach, Linda Lu, et al.
Publicado: (2016)

Evaluation of provider response to positive depression screenings and physician attitudes on integrating psychiatric pharmacist services in primary care settings
por: Denson, Brittany H., et al.
Publicado: (2018)

Outcomes of patient education practices to optimize the safe use of lithium: A literature review
por: Zolezzi, Monica, et al.
Publicado: (2018)

Kinetic Oscillation Stimulation as Treatment of Acute Migraine: A Randomized, Controlled Pilot Study
por: Juto, Jan-Erik, et al.
Publicado: (2015)

A stated preference survey to explore patient preferences for novel preventive migraine treatments
por: Hubig, Lena T., et al.
Publicado: (2022)

Pilot Study of Injection of OnabotulinumtoxinA Toward the Sphenopalatine Ganglion for the Treatment of Classical Trigeminal Neuralgia
por: Crespi, Joan, et al.
Publicado: (2019)

Effect of Fremanezumab Monthly and Quarterly Doses on Efficacy Responses
por: Fiedler‐Kelly, Jill, et al.
Publicado: (2020)

Evaluation of the 6‐item Identify Chronic Migraine screener in a large medical group
por: Pavlovic, Jelena M., et al.
Publicado: (2021)

Preventive migraine treatment with eptinezumab reduced acute headache medication and headache frequency to below diagnostic thresholds in patients with chronic migraine and medication‐overuse headache
por: Marmura, Michael J., et al.
Publicado: (2021)

Discontinuation of Acute Prescription Medication for Migraine: Results From the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study
por: Lipton, Richard B., et al.
Publicado: (2019)

IMPROVING THE EFFECTIVENESS AND EFFICIENCY OF EVIDENCE PRODUCTION FOR HEALTH TECHNOLOGY ASSESSMENT
por: Facey, Karen, et al.
Publicado: (2015)

Effect of Galcanezumab Following Treatment Cessation in Patients With Migraine: Results From 2 Randomized Phase 3 Trials
por: Stauffer, Virginia L., et al.
Publicado: (2019)

Assessing Barriers to Chronic Migraine Consultation, Diagnosis, and Treatment: Results From the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study
por: Dodick, David W., et al.
Publicado: (2016)

Psychometric Validation of the Role Function Restrictive Domain of the Migraine Specific Quality‐of‐Life Questionnaire Version 2.1 Electronic Patient‐Reported Outcome in Patients With Episodic and Chronic Migraine
por: Speck, Rebecca M., et al.
Publicado: (2019)

The Effect of Psychiatric Comorbidities on Headache‐Related Disability in Migraine: Results From the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study
por: Lipton, Richard B., et al.
Publicado: (2020)

Terraforming Pilot at IdeaSquare
por: Poulaillon, Jimmy
Publicado: (2023)

Use of Most Bothersome Symptom as a Coprimary Endpoint in Migraine Clinical Trials: A Post‐Hoc Analysis of the Pivotal ZOTRIP Randomized, Controlled Trial
por: Dodick, David W., et al.
Publicado: (2018)

Efficacy of Galcanezumab for Migraine Prevention in Patients With a Medical History of Anxiety and/or Depression: A Post Hoc Analysis of the Phase 3, Randomized, Double‐Blind, Placebo‐Controlled REGAIN, and Pooled EVOLVE‐1 and EVOLVE‐2 Studies
por: Smitherman, Todd A., et al.
Publicado: (2020)

Improvements in quality of life and work productivity with up to 6 months of fremanezumab treatment in patients with episodic and chronic migraine and documented inadequate response to 2 to 4 classes of migraine‐preventive medications in the phase 3b FOCUS study
por: Spierings, Egilius L. H., et al.
Publicado: (2021)

Matching‐adjusted indirect comparisons of oral rimegepant versus placebo, erenumab, and galcanezumab examining monthly migraine days and health‐related quality of life in the treatment of migraine
por: Popoff, Evan, et al.
Publicado: (2021)

Likelihood of response with subsequent dosing for patients with migraine and initial suboptimal response with eptinezumab: A post hoc analysis of two placebo‐controlled randomized clinical trials
por: Schim, Jack D., et al.
Publicado: (2022)

Onset of Efficacy Following Oral Treatment With Lasmiditan for the Acute Treatment of Migraine: Integrated Results From 2 Randomized Double‐Blind Placebo‐Controlled Phase 3 Clinical Studies
por: Ashina, Messoud, et al.
Publicado: (2019)

Diagnostic accuracy of an artificial intelligence online engine in migraine: A multi‐center study
por: Cowan, Robert P., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jaqiirbr4n8vs84piufe3t1rva